我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Is There Any Cause for Concern in Patients Who Have Their First Helicobacter Like Organism Test Positive?

Syed Nouman Mohsin

Aim: To assess the existing first line triple therapy in patients for possible resistance.
Materials and Methods: Retrospective assessment of all patients who had their Helicobacter pylori positive with biopsies taken for various reasons during gastroscopy followed by confirmation of eradication with 13C-urea test over a time period of one year.
Results: Out of 1548 gastroscopies where CLO (Campylobacter-like Organism test) was taken that were done over a time period of 1 year, 242 (15.63%) patients had their helicobacter-like organism test positive. Triple regime was prescribed for eradication in all of them and retesting with 13C urea breath test after six weeks reveal successful eradication in 192 (79.3%) and failed eradication in only 50 (20.7%) of the patients.
Conclusion: The first line regime for the eradication of Helicobacter pylori used in our hospital is efficient for the eradication and there is no any amendment that has to be made in the current regime.